Afya Limited (AFYA)
Afya Limited (AFYA) Stock Price, Analysis & Data
| Bid | 9.81 |
| Market Cap | 1.27B |
| Revenue (ttm) | 3.83B |
| Net Income (ttm) | 782.27M |
| Beta | 0.38 |
| EPS (ttm) | 1.67 |
| PE Ratio (ttm) | 8.29 |
| Forward PE | 7.09 |
| P/B (ttm) | 1.32 |
| P/S (ttm) | 0.33 |
| Earnings Date | Nov 12, 2026 |
| Ask | 17.15 |
| Volume | 167,555 |
| Avg. Volume (20D) | 104,640 |
| Open | 13.40 |
| Previous Close | 13.41 |
| Day's Range | 13.33 - 13.90 |
| 52-Week Range | 13.00 - 16.50 |
| Analyst | Sell |
| Price Target | 15.97 (15.39%) |
| Dividends | $0.66 (4.74%) |
| Ex-Dividend Date | Mar 25, 2026 |
About AFYA
Afya Limited operates as a medical education group in Brazil. The company operates in three segments: Undergraduate, Continuing Education, and Medical Practice Solutions. The Undergraduate segment offers educational services through undergraduate courses related to medical school, health sciences, and other non-health undergraduate programs, including medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy...
Financial Performance
In 2025, Afya's revenue was 3.7B, an increase of 11.89% compared to the previous year's 3.3B. Earnings were 752.46M, an increase of 19.15%.
Financial StatementsAnalyst Forecast
According to 9 analyst ratings, the average rating for AFYA stock is "Sell". The 12-month stock price forecast is 15.97, which is upside of 15.39% from the latest price.
Stock ForecastsEarnings Surprise
Analysts project revenue of ... Upgrade
